Clinical Trial

Developing Resilience in Transgender and Nonbinary Individuals - Exploring the Impact of Social Challenges in the Metaverse

Study acronym: RESILIDENT
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to test the effectiveness of conducting a support group in the Metaverse designed to develop and/or improve resilience in gender diverse people. By exploring the impact of different social challenges in a virtual environment, the main question it aims to answer is whether this approach on conducting support group sessions with gender diverse people will strengthen their resilience and associated abilities (self-compassion) compared to a control group and a waitlist.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-04; most recent amendment 2026-05-24.
Status change: Not Yet Recruiting → Recruiting 2025-07-29
Trial Details
NCT Number NCT06959992
Lead Sponsor University of Bucharest
Conditions Resilience,Psychological, Well-Being, Psychological, Self-Compassion
Enrollment 123 participants
Start Date 2025-09-01
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-28